Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Silence Therapeutics PLC

www.silence-therapeutics.com

Latest From Aptanomics SA

Investing in French Biotech--When It's Not Too French

Neuro 3d's €31.5 million third round late in 2004 was one of France's largest private biotech financings for years. But none of the investors are looking to France to provide the exit opportunities, which are more likely to be found in M&A, or in Switzerland.
BioPharmaceutical Business Strategies

Investing in French Biotech--When It's Not Too French

Neuro 3d's €31.5 million third round late in 2004 was one of France's largest private biotech financings for years. But none of the investors are looking to France to provide the exit opportunities, which are more likely to be found in M&A, or in Switzerland.
BioPharmaceutical Business Strategies

Aptanomics SA

French start-up Aptanomics is using peptide aptamers to validate novel intracellular targets.
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
    • Liposomes
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Ophthalmic
  • Respiratory, Pulmonary
  • Alias(es)
  • SR Pharma PLC
  • Stanford Rook Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Silence Therapeutics PLC
  • Senior Management
  • Ali Mortazavi, PhD, CEO
    Timothy Freeborn, Fin. Dir. & Secretary
    Jorg Kaufmann, PhD, CSO
  • Contact Info
  • Silence Therapeutics PLC
    Phone: (44) (0)20 3700 9711
    1 Lyric Square
    London, W6 0NB
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register